A short and convenient synthesis of new 1,2-disubstituted carbocyclic nucleoside analogues of pyrimidine based on a cyclopentene ring

Synthesis

Volumn , Issue 4, 2004, Pages 543-548

  Gonzalez Moa M J ^a   Besada, P ^a   Teijeira, M ^a   Teran C ^a   Uriarte, E ^b  

^a UNIVERSITY OF VIGO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Amino alcohols; Carbocycles; Heterocycles; Nucleosides; Reductions

Indexed keywords

CHEMICAL BONDS; HALOGENATION; SYNTHESIS (CHEMICAL);

CYCLOPENTENE RING; URACIL DERIVATIVES;

AROMATIC COMPOUNDS;

1 (2 HYDROXYMETHYL 4 CYCLOPENTENYL)URACIL; 5 BROMO 1 (2 HYDROXYMETHYL 4 CYCLOPENTENYL)URACIL; CYCLOPENTENE DERIVATIVE; NUCLEOSIDE ANALOG; PYRIMIDINE DERIVATIVE; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ARTICLE; BROMINATION; CHEMICAL BOND; CHLORINATION; DRUG SYNTHESIS; HALOGENATION; IODINATION; QUANTUM YIELD; REACTION ANALYSIS; STRUCTURE ANALYSIS;

EID: 18144435108     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815975     Document Type: Article

References (25)

1. Chu, C. K.; Baker, D. C. Nucleosides and Nucleotides as Antitumor and Antiviral Agents; Plenum Press: New York, 1993.
2. Cheson, D. K.; Keating, M. J.; Plunkett, W. Nucleoside Analogs in Cancer Therapy; Marcel Dekker: New York, 1997.
3. Mansour, T. S.; Storer, R. Curr. Pharm. Design 1997, 3, 227.
4. Ichikawa, E.; Kato, K. Curr. Med. Chem. 2001, 8, 385.
5. Agrofoglio, L. A.; Challand, S. R. Acyclic, Carbocyclic and L-Nucleosides; Klumer Academic Publishers: Dordrecht, 1998.
6. Simons, C. Nucleoside Mimetics their Chemistry and Biological Properties; Gordon and Breach Science Publishers: Amsterdam, 2001.
7. Marquez, V. E. Adv. Antiviral Drug Des. 1996, 2, 89.
8. Zhu, X.-F. Nucleosides, Nucleotides Nucleic Acids 2000, 19, 651.
9. De Clercq, E. Nat. Rev. Drug Discovery 2002, 1, 13.
10. Estrada, E.; Uriarte, E.; Montero, A.; Teijeira, M.; Santana, L.; De Clercq, E. J. Med. Chem. 2000, 43, 1975.
11. Santana, L.; Teijeira, M.; Terán, C.; Uriarte, E.; Viña, D. Synthesis 2001, 1532.
12. Besada, P.; González-Moa, M. J.; Terán, C.; Santana, L.; Uriarte, E. Synthesis 2002, 2445.
13. (a) Bridges, G. S.; Ahmed, S. P.; Sunkara, P. S.; McCarty, J. R.; Tyms, A. S. Antivir. Res. 1995, 27, 325.
14. (b) Foye, W. O. Cancer Chemotherapeutic Agents; American Chemical Society: Washington, 1995.
15. (a) Farina, V.; Hauck, S. I. Synlett 1991, 157.
16. (b) Robins, M. J.; Barr, P. J. J. Org. Chem. 1983, 48, 1854.
17. (c) Tsvetkov, A. V.; Latyshev, G. V.; Lukashev, N. V.; Beletskaya, I. P. Tetrahedron Lett. 2002, 43, 7267.
18. Sheally, Y. F.; O'Dell, C. A. J. Heterocycl. Chem. 1976, 13, 1041.
19. Hronowski, L. J.; Szarek, W. A. Can. J. Chem. 1985, 63, 2787.
20. Santana, L.; Teijeira, M.; Uriarte, E. J. Heterocycl. Chem. 1999, 36, 1.
21. (a) Tietze, L. F.; Schemeider, C.; Pretor, M. Synthesis 1993, 1079.
22. (b) Fernández, F.; García-Mera, X.; Morales, M.; Rodríguez-Borges, J. E. Synthesis 2001, 239.
23. Katagiri, N.; Muto, M.; Nomura, M.; Higashikawa, T.; Kaneko, C. Chem. Pharm. Bull. 1991, 39, 1112.
24. Katagiri, N.; Nomura, M.; Sato, H.; Kaneko, C.; Yusa, K.; Tsuruo, T. J. Med. Chem. 1992, 35, 1882.
25. Awano, H.; Shuto, S.; Baba, M.; Kira, T.; Shigeta, S.; Matsuda, A. Bioorg. Med. Chem. Lett. 1994, 4, 367.